Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pure Bioscience (PURE)
OTHER OTC:PURE
Holding PURE?
Track your performance easily
PURE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.06 - $0.17
Previous Close$0.11
Volume17.00K
Average Volume (3M)28.08K
Market Cap
$12.09M
Enterprise Value$11.74M
Total Cash (Recent Filing)$349.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.39
Next Earnings
Dec 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding111,856,473
10 Day Avg. Volume37,821
30 Day Avg. Volume28,079
Standard Deviation0.26
R-Squared0.00005
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-4.00
Price to Sales (P/S)8.72
Price to Cash Flow (P/CF)-7.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.98
Enterprise Value/Gross Profit10.19
Enterprise Value/Ebitda-3.79
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pure Bioscience News
Ownership Overview
40.91%
Insiders
0.72% Other Institutional Investors
58.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PURE FAQ
What was Pure Bioscience’s price range in the past 12 months?
Pure Bioscience lowest stock price was $0.06 and its highest was $0.17 in the past 12 months.
What is Pure Bioscience’s market cap?
Currently, no data Available
When is Pure Bioscience’s upcoming earnings report date?
Pure Bioscience’s upcoming earnings report date is Dec 12, 2024 which is in 15 days.
How were Pure Bioscience’s earnings last quarter?
Pure Bioscience released its earnings results on Oct 29, 2024. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
Is Pure Bioscience overvalued?
According to Wall Street analysts Pure Bioscience’s price is currently Overvalued.
Does Pure Bioscience pay dividends?
Pure Bioscience does not currently pay dividends.
What is Pure Bioscience’s EPS estimate?
Pure Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pure Bioscience have?
Pure Bioscience has 111,856,476 shares outstanding.
What happened to Pure Bioscience’s price movement after its last earnings report?
Pure Bioscience reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Pure Bioscience?
Currently, no hedge funds are holding shares in PURE
---
Pure Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.88%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-55.18%
Trailing 12-Months
Company Description
Pure Bioscience
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
---
Technical Analysis
---